The Indian Journal of Medical Research (INDIAN J MED RES)

Publisher: Indian Council of Medical Research, Medknow Publications

Journal description

The Indian Journal of Medical Research (IJMR) is one of the oldest medical Journals not only in India, but probably in Asia, as it started in the year 1913. The Journal was started as a quarterly (4 issues/year) in 1913 and made bimonthly (6 issues/year) in 1958. It was made monthly (12 issues/year) in the year 1964. The Journal is being indexed and abstracted by all major global current awareness and alerting services (Annexure). The Indian Journal of Medical Research is published monthly, in two volumes and 12 issues per year. The IJMR publishes peer reviewed quality biomedical research in the form of original research articles, review articles, short papers and short notes. Special issues and supplements are published in addition to the regular issues.

Current impact factor: 1.40

Impact Factor Rankings

2015 Impact Factor Available summer 2016
2014 Impact Factor 1.396
2013 Impact Factor 1.661
2012 Impact Factor 2.061
2011 Impact Factor 1.837
2010 Impact Factor 1.826
2009 Impact Factor 1.516
2008 Impact Factor 1.883
2007 Impact Factor 1.67
2006 Impact Factor 1.224
2005 Impact Factor 0.869
2004 Impact Factor 0.6
2003 Impact Factor 0.452
2002 Impact Factor 0.445
2001 Impact Factor 0.34
2000 Impact Factor 0.383
1999 Impact Factor 0.365
1998 Impact Factor 0.4
1997 Impact Factor 0.318
1996 Impact Factor 0.251
1995 Impact Factor 0.198

Impact factor over time

Impact factor

Additional details

5-year impact 1.93
Cited half-life 6.80
Immediacy index 0.26
Eigenfactor 0.01
Article influence 0.50
Website Indian Journal of Medical Research website
Other titles Indian journal of medical research (New Delhi, India: 1994)
ISSN 0971-5916
OCLC 59369085
Material type Periodical, Internet resource
Document type Internet Resource, Journal / Magazine / Newspaper

Publisher details

Medknow Publications

  • Pre-print
    • Author can archive a pre-print version
  • Post-print
    • Author can archive a post-print version
  • Conditions
    • Non-commercial
    • Publisher's version/PDF may be used
    • Creative Commons Attribution Non-Commercial Share Alike License
    • Published source must be acknowledged
    • All titles are open access journals
  • Classification

Publications in this journal

  • The Indian Journal of Medical Research 02/2016;

  • The Indian Journal of Medical Research 10/2015; 142(October):459-461.

  • The Indian Journal of Medical Research 09/2015; 142(2):227-8. DOI:10.4103/0971-5916.164276
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background & objectives: Imatinib is the standard first-line treatment for chronic myeloid leukaemia (CML) patients. About 20 to 30 per cent patients develop resistance to imatinib and fail imatinib treatment. One of the mechanisms proposed is varying expression levels of the drug transporters. This study was aimed to determine the expression levels of imatinib transporter genes (OCT1, ABCB1, ABCG2) in CML patients and to correlate these levels with molecular response. Methods: Sixty three CML chronic phase patients who were on 400 mg/day imatinib for more than two years were considered for gene expression analysis study for OCT1, ABCB1 and ABCG2 genes. These were divided into responders and non-responders. The relative transcript expression levels of the three genes were compared between these two categories. The association between the expression values of these three genes was also determined. Results: No significant difference in the expression levels of OCT1, ABCB1 and ABCG2 was found between the two categories. The median transcript expression levels of OCT1, ABCB1 and ABCG2 genes in responders were 26.54, 10.78 and 0.64 versus 33.48, 7.09 and 0.53 in non-responders, respectively. A positive association was observed between the expression of the ABCB1 and ABCG2 transporter genes (r=0.407, P<0.05) while no association was observed between the expression of either of the ABC transporter genes with the OCT1 gene. Interpretation & conclusions: Our findings demonstrated that the mRNA expression levels of imatinib transporter genes were not correlated with molecular response in CML patients. Further studies need to be done on a large sample of CML patients to confirm these findings.
    The Indian Journal of Medical Research 09/2015; 142(2):175-82. DOI:10.4103/0971-5916.164250
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background & objectives: Inequity in the use of health care services is an important factor affecting the maternal and child survival. In southern Odisha, India, the health indicators remained below compared to the s0 tate and national average. This study identifies various equity issues at individual and community levels that influence women's choice affecting the utilization of maternal health services in a district in southern Odisha. Methods: A qualitative study was carried out in Gajam district, rural region of south Odisha. Ten in-depth interviews were carried out till data saturation with women having less than one year child and 10 focus group discussions with the average eight women in each group having less than five year old child, community and health care providers separately. A total of 120 respondents were included in the study using in-depth interview and focus group discussions. Results: The important determinants in utilization of health care services by women emerging from the study were transportation and financial constraints. In addition, it was found that divergent aetiological concepts and low perceived hospital benefits of the women and community were equally important determinants. Further, community had different perceptions and interpretations of danger signs influencing the risk approach and health care seeking behaviour. Interpretation & conclusions: Our findings show that to increase the utilization of health care services, the grass root health workers should be made aware of specific social determinants of risk, perceptions and preferences. m0 ore attention should be given to the transportation system, and its operational feasibility. The husband of the women and the elders of the family should be considered as an important unit of interjection. A more individualized antenatal consultation could be provided by taking into account women's perception of risk and their explanatory models.
    The Indian Journal of Medical Research 09/2015; 142(2):183-9. DOI:10.4103/0971-5916.164251

  • The Indian Journal of Medical Research 09/2015; 142(2):106-8. DOI:10.4103/0971-5916.164211

  • The Indian Journal of Medical Research 09/2015; 142(2):216-9. DOI:10.4103/0971-5916.164261
  • [Show abstract] [Hide abstract]
    ABSTRACT: Down syndrome (DS) is one of the most common chromosomal disorders, occurring in one out of 700-1000 live births, and the most common cause of mental retardation. Thyroid dysfunction is the most typical endocrine abnormality in patients with DS. It is well known that thyroid dysfunction is highly prevalent in children and adults with DS and that both hypothyroidism and hyperthyroidism are more common in patients with DS than in the general population. Increasing evidence has shown that DS individuals are under unusual increased oxidative stress, which may be involved in the higher prevalence and severity of a number of pathologies associated with the syndrome, as well as the accelerated ageing observed in these individuals. The gene for Cu/Zn superoxide dismutase (SOD1) is coded on chromosome 21 and it is overexpressed (~50%) resulting in an increase of reactive oxygen species (ROS) due to overproduction of hydrogen peroxide (H 2 O 2 ). ROS leads to oxidative damage of DNA, proteins and lipids, therefore, oxidative stress may play an important role in the pathogenesis of DS.
    The Indian Journal of Medical Research 09/2015; 142(2):113-9. DOI:10.4103/0971-5916.164218
  • [Show abstract] [Hide abstract]
    ABSTRACT: A survey was conducted to ascertain practice of antimicrobial stewardship programme (AMSP) in India for 2013. A total of 20 health care institutions (HCI) responded to a detailed questionnaire. All the institutions contacted were tertiary care HCI, of which 12 were funded by government (GHCI) and 8 were corporate/private HCI (PHCI). Further, all catered to both rural and urban populations and were spread across the country. Written documents were available with 40 per cent for AMSP, 75 per cent for hospital infection control (HIC) and HIC guidelines and 65 per cent for antimicrobial agents (AMA) prescription guidelines. Records were maintained for health care associated infections (HCAI) by 60 per cent HCI. Antimicrobial resistance (AMR) data were being analysed by 80 per cent HCI. AMA usage data were analysed by only 25 per cent HCI and AMA prescription audit and feedback by 30 per cent. PHCI performed better than GHCI across all fields of AMSP. The main contributory factor was possibly the much higher level of accreditation of PHCI hospitals and their diagnostic laboratories. The absence of infectious diseases physicians and clinical pharmacists is worrying and demands careful attention.
    The Indian Journal of Medical Research 09/2015; 142(2):130-8. DOI:10.4103/0971-5916.164228
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background & objectives: Amyloid β-peptide (Aβ) has been shown to be responsible for senile plaque formation and cell damage in Alzheimer's disease (AD). This study was aimed to explore the role of natural compound icariin on the aggregation and the cytotoxicity of Aβ in vitro. Methods: Thioflavin T (ThT) fluorescence assay and transmission electron microscopy (TEM) imaging were done to determine the influence of icariin on the aggregation of Aβ1-42 peptide. MTT assay was used to evaluate the protective effect of icariin on Aβ1-42 induced cytotoxicity in neuroblastoma SH-SY5Y cells. Results: Icariin inhibited Aβ1-42 aggregation in a dose-dependent manner. Additionally, icariin also prevented the cytotoxicity of Aβ1-42 in SH-SY5Y cells by decreasing the production of peroxide hydrogen during the aggregation of this peptide. Interpretation & conclusions: The results indicated a novel antagonistic role of icariin in the neurotoxicity of Aβ1-42 via inhibiting its aggregation, suggesting that icariin might have potential therapeutic benefits to delay or modify the progression of AD.
    The Indian Journal of Medical Research 09/2015; 142(2):190-5. DOI:10.4103/0971-5916.164254
  • [Show abstract] [Hide abstract]
    ABSTRACT: Background & objectives: Anthrax caused by Bacillus anthracis is primarily a disease of herbivorous animals, although several mammals are vulnerable to it. ELISA is the most widely accepted serodiagnostic assay for large scale surveillance of cutaneous anthrax. The aims of this study were to develop and evaluate a quantitative ELISA for determination of IgG antibodies against B. anthracis protective antigen (PA) in human cutaneous anthrax cases. Methods: Quantitative ELISA was developed using the recombinant PA for coating and standard reference serum AVR801 for quantification. A total of 116 human test and control serum samples were used in the study. The assay was evaluated for its precision, accuracy and linearity. Results: The minimum detection limit and lower limit of quantification of the assay for anti-PA IgG were 3.2 and 4 µg/ml, respectively. The serum samples collected from the anthrax infected patients were found to have anti-PA IgG concentrations of 5.2 to 166.3 µg/ml. The intra-assay precision per cent CV within an assay and within an operator ranged from 0.99 to 7.4 per cent and 1.7 to 3.9 per cent, respectively. The accuracy of the assay was high with a per cent error of 6.5 - 24.1 per cent. The described assay was found to be linear between the range of 4 to 80 ng/ml (R [2] =0.9982; slope=0.9186; intercept = 0.1108). Interpretation & conclusions: The results suggested that the developed assay could be a useful tool for quantification of anti-PA IgG response in human after anthrax infection or vaccination.
    The Indian Journal of Medical Research 09/2015; 142(2):196-204. DOI:10.4103/0971-5916.164258

  • The Indian Journal of Medical Research 09/2015; 142(2):225-6. DOI:10.4103/0971-5916.164264

  • The Indian Journal of Medical Research 09/2015; 142(2):229-30. DOI:10.4103/0971-5916.164277

  • The Indian Journal of Medical Research 09/2015; 142(2):103-5. DOI:10.4103/0971-5916.164210